Small Cap Watch: 4 Trending Stocks That Are Making Big Moves Today
NEW YORK, NY / ACCESSWIRE / April 28, 2016 / The Stock Expert is issuing a report on four stocks that are performing well this Thursday. SRPT, AEZS, ADMS and PACD are on high volume alert. Continue reading to find out why. – To get daily alerts on the hottest stocks on the Nasdaq/NYSE subscribe to our newsletter at TheStockExpert.com.
Sarepta Therapeutics, Inc. (NASDAQ: SRPT) The company is a biopharmaceutical company, focuses on the discovery and development of RNA-based therapeutics for the treatment of rare, infectious, and other diseases.
Shares of SRPT are trading higher today by over 19% after a recent media reported suggested that the company can still secure approval for its DMD treatment despite being down voted earlier.
The surprise news has bolstered the stock, which is trading off heavier than usual volume after the piece of news was released.
Subscribe Free To Receive Alerts Like These Sent To Your Inbox Get Your Free Membership Now.
Aeterna Zentaris Inc. (NASDAQ: AEZS) Is a specialty biopharmaceutical company, engages in developing and commercializing novel treatments in oncology, endocrinology, and women’s health.
Shares of AEZS are trading higher by over 6% this morning after announcing that it acquired exclusive US promotional rights to Apifiny prostate cancer blood test pursuant to a new co-marketing agreement with Armune BioScience.
Share are already trading 2 times its average volume after making the announcement just after market close yesterday.
Like What You See? Get These Alerts and Many More on NASDAQ Companies before They Rally, Find Out More Here.
Adamas Pharmaceuticals, Inc. (NASDAQ: ADMS) Is a pharmaceutical company, focuses on the development and commercialization of therapeutics targeting chronic disorders of the central nervous systems.
The company announced today that its Phase 3 trial (EASE LID 3) evaluating ADS-5102 (amantadine HCl) extended-release capsules for the treatment of levodopa-induced dyskinesia associated with Parkinson’s disease met its primary and key secondary endpoints.
However, the stock is not acting positively to the news and is trading lower by 6%.
Get the Information You Need To Stay Informed and Up To Date On The Hottest NASDAQ Plays Get Them Here.
Pacific Drilling S.A. (NYSE: PACD) Together with its subsidiaries, operates as an offshore drilling contractor. It provides offshore drilling services to the oil and natural gas industry.
Shares of PACD are trading higher today by over 18%, continuing on the gains it has been making all week this week. The stock is also receiving a major boost in volume.
However, with an RSI (relative strength index) of over 78, the stock is trading in highly overbought levels and could be due for small pull back.
NASDAQ Stock Alerts: Check Them Out Here To Receive Our Winning NASDAQ & NYSE Stock Alerts For Free.
About TheStockExpert.com
The Stock Expert is a newsletter alert service that focuses on companies on the NASDAQ & NYSE. We only highlight quality companies with big news on high volume days. This commitment provides our subscribers with only the best recommendations of companies for short and long-term investments.
To receive free text message alerts on your phone, compose a new text message to the number 95577 with the word “STOCKEXPERT”.
Disclosure: The information, opinions and analysis contained in this report are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We do not accept any responsibility or liability for any losses, damages or costs arising from an investor’s or other person’s reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities, nor a recommendation of any security. Past gains are not representative of future gains. The Stock Expert has not been compensated nor does it expect to receive any compensation for distribution of its opinions and publicly available information regarding the companies reported in this investment opinion article at this time. The opinions contained herein contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. When used herein, the words “anticipate,” “intend,” “estimate,” “believe,” “expect,” “plans,” “should,” “potential,” “forecast,” and variations of such words and similar expressions are intended to identify forward-looking statements. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. A company’s actual results could differ materially from those described in any forward-looking statements contained herein. The Stock Expert is not a licensed broker, broker dealer, market maker, investment advisor, analyst or underwriter. We recommend that you use the information found herein as an initial starting point for conducting your own research in order to determine your own personal opinion of the companies discussed herein before deciding whether or not to invest. You should seek such investment, tax, financial, accounting or legal advice appropriate for your particular circumstances. Information about many publicly traded companies and other investor resources can be found at www.sec.gov. Investing in securities is speculative and carries risk. Please visit TheStockExpert.com/disclaimer website for a more detailed discussion of risks and disclosures.
Contact:
Justin Skibinski
The Stock Expert
info@thestockexpert.com
SOURCE: The Stock Expert
ReleaseID: 439340